ProSomnus, Inc.
ProSomnus, Inc. (OSA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OSA · as of Jun 8, 2026
Key Statistics
Explore ProSomnus, Inc. Data
osa stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
osa competitorsOSA
BIOR
CNTG
CSCI
NLTX
NUROStock Performance
Full HistoryAbout ProSomnus, Inc.
ProSomnus, Inc. develops and provides specialized oral appliance therapy solutions crafted to alleviate obstructive sleep apnea (OSA). This enterprise, which originated in 2016, maintains its headquar…
what is prosomnus, inc. · osa stock overview · prosomnus, inc. company profile · who is prosomnus, inc. ceo · osa NASDAQ · prosomnus, inc. headquarters · prosomnus, inc. business segments
About Stock Overview & Key Data
ProSomnus, Inc. (OSA) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Jul 28, 2021. As of the latest trading session, OSA stock price is $0.47, with a market capitalization of $8.2M. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 2 Wall Street analysts, the consensus rating for ProSomnus, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, ProSomnus, Inc. reported revenue of $27.7M and net income of -$24.1M. For detailed data — including ProSomnus, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, ProSomnus, Inc. (OSA) stock price is $0.47. The stock is traded on NASDAQ under the ticker symbol OSA. The 52-week range is $0.47 – $0.50.